NCT07274514Completed
Virtual Reality on Balance of Parkinson's Disease
Effects of Immersive Virtual Reality on Balance of Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 13 Jul 2026
Brief summary (registry, in English)
This study, titled: Effectiveness of immersive virtual reality on balance in people with Parkinson's disease. Is a randomized clinical trial conducted at Zaragoza Parkinson's Association in Spain. It aims to evaluate the effectiveness of a immersive virtual reality program in enhancing balance for patients with Parkinson.s disease (PD). PD is a neurodegenerative disease that has a major impact on patients' balance and gait, affecting their quality of life. Physical rehabilitation is crucial for maintaining and improving balance, and immersive virtual reality promises to be an alternative for improving outcomes in patients with PD.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 57 (actual)
- First submitted
- 21 Aug 2025
- Start date
- 5 Feb 2025
- Primary completion date
- 27 Feb 2026
- Lead sponsor
- Instituto de Investigación Sanitaria Aragón
- Diseases
- Parkinson disease
- NCT number
- NCT07274514
What you commit to
- Study type: Interventional
- Participants enrolled: 57
- From 5 Feb 2025 to the primary completion date, 27 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Visual or auditory impairments that could interfere with the perception of information or trigger dizziness or epilepsy
- Musculoskeletal conditions that hinder or prevent the execution of exercises or the ability to maintain a standing position for at least 20 minutes
- Psychiatric disorders such as moderate or severe depression diagnosed in the last year and impulse control disorders diagnosed in the last year
Other
- Score of 20 points on the Simulator Sickness Questionnaire (SSQ scale), indicating the presence of severe adverse symptoms
Who the study is looking for
- Diagnosis of PD confirmed by a neurologist
- Age between 55 and 90 years
- Hoehn \& Yahr Scale score of 1 to 4
- Cognitive level of 24 or higher on the Mini Mental Examination Test
- Ability to stand upright without assistance
Age in the registry: 55 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asociación de Parkinson de Aragón Coordinator of this site? Confirm its status | Zaragoza | Spain | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.